
Catalyst OrthoScience announced FDA 510(k) clearance for its Archer® Patient‑Specific Instrumentation (PSI), a suite of humeral and glenoid guides designed to translate 3D pre‑operative plans into the operating room. The system pairs with Archer® 3D Planning Software, supporting both anatomic and reverse shoulder arthroplasty. Catalyst has begun a limited market release with select surgeon partners to collect real‑world data before a broader launch. The company positions itself as one of the few providers offering patient‑specific guides for both glenoid and humerus components.

The article updates the classic six‑factor framework for medical‑device commercialization, highlighting that Technological Feasibility, Market Size, and Reimbursement Potential remain top‑ranked but now demand AI integration, digital‑health ecosystem compatibility, and early payer engagement. Regulatory pathways have shifted dramatically with the...

Continuous cardiac monitoring via wearable ECG devices is reshaping clinical trials and post‑market care. Recent studies show that 14‑day monitoring after cardiac surgery uncovered atrial fibrillation in 24% of patients, many of which were missed until three‑month follow‑ups. In epilepsy...

Fresenius Medical Care has adopted PTC’s digital‑thread platform to create an intelligent product lifecycle that unifies design, quality and manufacturing data. The solution builds a shared product data foundation, enhancing traceability of requirements, design changes, and compliance documentation across cross‑functional...